LRRC39
gene geneOn this page
Also known as MGC14816myomasp
Summary
LRRC39 (leucine rich repeat containing 39, HGNC:28228) is a protein-coding gene on chromosome 1p21.2, encoding Leucine-rich repeat-containing protein 39 (Q96DD0). Component of the sarcomeric M-band which plays a role in myocyte response to biomechanical stress.
Predicted to be involved in intracellular signal transduction. Predicted to be located in M band.
Source: NCBI Gene 127495 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_144620
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28228 |
| Approved symbol | LRRC39 |
| Name | leucine rich repeat containing 39 |
| Location | 1p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC14816, myomasp |
| Ensembl gene | ENSG00000122477 |
| Ensembl biotype | protein_coding |
| Entrez | 127495 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000342895, ENST00000370137, ENST00000370138, ENST00000853203, ENST00000853204, ENST00000853205, ENST00000962771, ENST00000962772, ENST00000962773
RefSeq mRNA: 4 — MANE Select: NM_144620
NM_001256385, NM_001256386, NM_001256387, NM_144620
CCDS: CCDS58014, CCDS766
Canonical transcript exons
ENST00000370137 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000831286 | 100158231 | 100158367 |
| ENSE00000831287 | 100159259 | 100159415 |
| ENSE00001028850 | 100160466 | 100160571 |
| ENSE00001067730 | 100155051 | 100155203 |
| ENSE00001067731 | 100152385 | 100152524 |
| ENSE00001067733 | 100156172 | 100156317 |
| ENSE00001167907 | 100168404 | 100168594 |
| ENSE00001451915 | 100173331 | 100173370 |
| ENSE00003681662 | 100148448 | 100149097 |
| ENSE00003900749 | 100178135 | 100178256 |
Expression profiles
Bgee: expression breadth ubiquitous, 191 present calls, max score 99.37.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4943 / max 179.4404, expressed in 195 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 13511 | 1.2105 | 172 |
| 13510 | 0.1609 | 60 |
| 13509 | 0.0811 | 44 |
| 13512 | 0.0419 | 21 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 99.37 | gold quality |
| biceps brachii | UBERON:0001507 | 99.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.23 | gold quality |
| quadriceps femoris | UBERON:0001377 | 99.15 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.92 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 98.68 | gold quality |
| deltoid | UBERON:0001476 | 98.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.42 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.16 | gold quality |
| myocardium | UBERON:0002349 | 97.87 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 97.63 | gold quality |
| heart right ventricle | UBERON:0002080 | 97.16 | gold quality |
| tibialis anterior | UBERON:0001385 | 96.41 | gold quality |
| apex of heart | UBERON:0002098 | 95.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.48 | gold quality |
| muscle of leg | UBERON:0001383 | 95.10 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.68 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.68 | gold quality |
| muscle tissue | UBERON:0002385 | 94.50 | gold quality |
| body of tongue | UBERON:0011876 | 94.24 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.33 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.14 | gold quality |
| heart | UBERON:0000948 | 91.49 | gold quality |
| sperm | CL:0000019 | 85.92 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.78 | gold quality |
| tongue | UBERON:0001723 | 84.13 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.42 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.45 | gold quality |
| left adrenal gland | UBERON:0001234 | 79.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.73 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
51 targeting LRRC39, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-9718 | 99.94 | 68.91 | 918 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-208A-5P | 99.42 | 70.83 | 1913 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
Literature-anchored findings (GeneRIF, showing 1)
- Reveal myomasp/LRRC39 as a previously unrecognized component of an M-band-associated signaling pathway that regulates cardiomyocyte gene expression in response to biomechanical stress. (PMID:20847312)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lrrc39 | ENSDARG00000071465 |
| mus_musculus | Lrrc39 | ENSMUSG00000027961 |
| rattus_norvegicus | Lrrc39 | ENSRNOG00000015117 |
Paralogs (31): LRRC7 (ENSG00000033122), PHLPP2 (ENSG00000040199), LRRC40 (ENSG00000066557), LRCH4 (ENSG00000077454), PHLPP1 (ENSG00000081913), SHOC2 (ENSG00000108061), ERBIN (ENSG00000112851), LRCH2 (ENSG00000130224), LRCH1 (ENSG00000136141), LRRC8A (ENSG00000136802), LRRC1 (ENSG00000137269), MFHAS1 (ENSG00000147324), LRRC27 (ENSG00000148814), LRRK1 (ENSG00000154237), LRRC58 (ENSG00000163428), LRRC2 (ENSG00000163827), LRRC18 (ENSG00000165383), LRRC28 (ENSG00000168904), LRRC8E (ENSG00000171017), LRRC8C (ENSG00000171488), LRRC8D (ENSG00000171492), PIDD1 (ENSG00000177595), SCRIB (ENSG00000180900), LRCH3 (ENSG00000186001), LRRIQ4 (ENSG00000188306), LRRC8B (ENSG00000197147), LRRC10 (ENSG00000198812), LRRC10B (ENSG00000204950), LRRC30 (ENSG00000206422), LRRC69 (ENSG00000214954), LRRD1 (ENSG00000240720)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 39 — Q96DD0 (reviewed: Q96DD0)
Alternative names: Myosin-interacting M-band-associated stress-responsive protein
All UniProt accessions (1): Q96DD0
UniProt curated annotations — full annotation on UniProt →
Function. Component of the sarcomeric M-band which plays a role in myocyte response to biomechanical stress. May regulate expression of other M-band proteins via an SRF-dependent pathway. Important for normal contractile function in heart.
Subunit / interactions. Interacts with MYH7 (via C-terminus).
Subcellular location. Cytoplasm. Myofibril. Sarcomere. M line.
Tissue specificity. Highly expressed in skeletal muscle and heart. Not detected in other tissues tested.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96DD0-1 | 1 | yes |
| Q96DD0-2 | 2 |
RefSeq proteins (4): NP_001243314, NP_001243315, NP_001243316, NP_653221* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050216 | LRR_domain-containing | Family |
| IPR055414 | LRR_R13L4/SHOC2-like | Domain |
Pfam: PF13855, PF23598
UniProt features (13 total): repeat 9, chain 1, coiled-coil region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96DD0-F1 | 91.13 | 0.81 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
MEF2_02, HUI_MAPK14_TARGETS_UP, IRF1_Q6, chr1p21, HOXA4_Q2, GOCC_M_BAND, MEF2_03, GOCC_A_BAND, TCANNTGAY_SREBP1_01, CHEN_METABOLIC_SYNDROM_NETWORK, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, YANG_BCL3_TARGETS_UP, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_SUPRAMOLECULAR_POLYMER, MEF2D_TARGET_GENES
GO Biological Process (1): intracellular signal transduction (GO:0035556)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): M band (GO:0031430), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 2 |
| cellular anatomical structure | 2 |
| signal transduction | 1 |
| binding | 1 |
| A band | 1 |
Protein interactions and networks
STRING
1186 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC39 | RTCA | O00442 | 609 |
| LRRC39 | TRMT13 | Q9NUP7 | 601 |
| LRRC39 | DBT | P11182 | 578 |
| LRRC39 | FSD2 | A1L4K1 | 537 |
| LRRC39 | DPH5 | Q9H2P9 | 537 |
| LRRC39 | MYH7 | P12883 | 531 |
| LRRC39 | MBLAC2 | Q68D91 | 499 |
| LRRC39 | TERF2IP | Q9NYB0 | 482 |
| LRRC39 | PPP1R42 | Q7Z4L9 | 481 |
| LRRC39 | FITM1 | A5D6W6 | 471 |
| LRRC39 | FAM219A | Q8IW50 | 470 |
| LRRC39 | ZNF511 | Q8NB15 | 448 |
| LRRC39 | TTN | Q8WZ42 | 442 |
| LRRC39 | DRC11L | A6NCM1 | 429 |
| LRRC39 | MYOM3 | Q5VTT5 | 427 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC39 | MYH7 | psi-mi:“MI:0915”(physical association) | 0.510 |
| LRRC39 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| LRRC39 | MYH1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRC39 | MYH2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRC39 | MYH6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRC39 | CETN2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (29): GSN (Affinity Capture-MS), NINL (Affinity Capture-MS), LIMA1 (Affinity Capture-MS), CETN2 (Affinity Capture-MS), MIPOL1 (Affinity Capture-MS), SUGT1 (Affinity Capture-MS), CNNM4 (Affinity Capture-MS), RAD50 (Affinity Capture-MS), PTP4A1 (Affinity Capture-MS), MYO5B (Affinity Capture-MS), NINL (Affinity Capture-MS), MIPOL1 (Affinity Capture-MS), SUGT1 (Affinity Capture-MS), CETN2 (Affinity Capture-MS), RAD50 (Affinity Capture-MS)
ESM2 similar proteins: A4D1F6, A4IIK1, A6H6A4, A6NIV6, A6NM36, C0STK7, D3ZXS4, F1R6I3, F6R2G2, P14605, Q09562, Q32KX5, Q38SD2, Q3TX51, Q3UHC2, Q3UV48, Q3ZC49, Q4R6F0, Q54AX5, Q58A48, Q5G5E0, Q62192, Q65YW8, Q65Z91, Q66HD6, Q6AXL3, Q6GLE8, Q6GM71, Q6R5N8, Q6ZNQ3, Q7Z2Q7, Q86X40, Q8BGI7, Q8C0R9, Q8N456, Q8VDB8, Q96DD0, Q99467, Q99MB1, Q9BYS8
Diamond homologs: D3ZXS4, F1R6I3, Q3ZC49, Q8BGI7, Q96DD0, Q8VDB8, Q9BYS8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1339 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:100152373:CAAAT:C | donor_gain | 1.0000 |
| 1:100152377:T:C | donor_gain | 1.0000 |
| 1:100152380:TATA:T | donor_loss | 1.0000 |
| 1:100152383:A:C | donor_loss | 1.0000 |
| 1:100152384:CCTG:C | donor_gain | 1.0000 |
| 1:100152387:G:A | donor_gain | 1.0000 |
| 1:100152520:CAAAC:C | acceptor_gain | 1.0000 |
| 1:100152523:ACCTA:A | acceptor_loss | 1.0000 |
| 1:100152525:C:CA | acceptor_loss | 1.0000 |
| 1:100155040:CAA:C | donor_gain | 1.0000 |
| 1:100156166:TTTTA:T | donor_loss | 1.0000 |
| 1:100156167:TTTA:T | donor_loss | 1.0000 |
| 1:100156168:TTAC:T | donor_loss | 1.0000 |
| 1:100156169:TA:T | donor_loss | 1.0000 |
| 1:100156170:A:AT | donor_loss | 1.0000 |
| 1:100156171:CCTT:C | donor_loss | 1.0000 |
| 1:100156171:CCTTT:C | donor_gain | 1.0000 |
| 1:100156313:CTGAG:C | acceptor_gain | 1.0000 |
| 1:100156314:TGAG:T | acceptor_gain | 1.0000 |
| 1:100156316:AGC:A | acceptor_loss | 1.0000 |
| 1:100156317:GCTGA:G | acceptor_loss | 1.0000 |
| 1:100156318:C:CA | acceptor_loss | 1.0000 |
| 1:100156318:C:CC | acceptor_gain | 1.0000 |
| 1:100158226:CTAA:C | donor_loss | 1.0000 |
| 1:100158227:TAACC:T | donor_loss | 1.0000 |
| 1:100158228:AACC:A | donor_loss | 1.0000 |
| 1:100158230:CCT:C | donor_gain | 1.0000 |
| 1:100158230:CCTCT:C | donor_loss | 1.0000 |
| 1:100158301:AGTT:A | donor_gain | 1.0000 |
| 1:100158367:CCT:C | acceptor_loss | 1.0000 |
AlphaMissense
2206 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:100158343:A:G | L134P | 0.998 |
| 1:100159373:A:G | W88R | 0.998 |
| 1:100159373:A:T | W88R | 0.998 |
| 1:100156289:A:G | L181P | 0.997 |
| 1:100158274:A:G | L157P | 0.997 |
| 1:100156283:A:G | L183P | 0.996 |
| 1:100158258:G:C | N162K | 0.996 |
| 1:100158258:G:T | N162K | 0.996 |
| 1:100158268:A:G | L159P | 0.996 |
| 1:100152521:A:C | F272L | 0.995 |
| 1:100152521:A:T | F272L | 0.995 |
| 1:100152523:A:G | F272L | 0.995 |
| 1:100156220:A:G | L204P | 0.995 |
| 1:100156273:G:C | N186K | 0.995 |
| 1:100156273:G:T | N186K | 0.995 |
| 1:100158313:A:T | V144D | 0.995 |
| 1:100159291:C:G | R115P | 0.995 |
| 1:100155177:A:G | L229P | 0.994 |
| 1:100158333:G:C | S137R | 0.994 |
| 1:100158333:G:T | S137R | 0.994 |
| 1:100158335:T:G | S137R | 0.994 |
| 1:100160491:A:G | L65S | 0.994 |
| 1:100156224:A:G | W203R | 0.993 |
| 1:100156224:A:T | W203R | 0.993 |
| 1:100158268:A:C | L159R | 0.993 |
| 1:100158337:A:G | L136P | 0.993 |
| 1:100159287:G:C | N116K | 0.993 |
| 1:100159287:G:T | N116K | 0.993 |
| 1:100152519:A:T | V273D | 0.992 |
| 1:100155181:A:G | W228R | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000010624 (1:100156749 G>A), RS1000020668 (1:100161281 A>G), RS1000091392 (1:100150171 A>G), RS1000112530 (1:100168244 A>C), RS1000248172 (1:100164866 C>T), RS1000248585 (1:100153681 A>AT), RS1000322474 (1:100171810 A>G), RS1000374706 (1:100172144 T>C), RS1000458333 (1:100160829 T>G), RS1000523331 (1:100149219 T>C), RS1000531004 (1:100163098 A>G), RS1000595138 (1:100164496 G>A,T), RS1000680226 (1:100181656 G>T), RS1000937121 (1:100177783 C>G,T), RS1001059189 (1:100176132 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009195_7 | Temporal pole volume | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| lasiocarpine | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| coumarin | increases phosphorylation | 1 |
| pentanal | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.